Table 1.
Clinical Features of the Study Subjects
| CC | TT | P Value | |
|---|---|---|---|
| n | 7 | 7 | |
| Age, y | 16.4 ± 0.62 | 16.2 ± 0.78 | .54 |
| Gender (males/females), n | 2/5 | 2/5 | 1.00 |
| Ethnicity (C/AA/H), n | 3/1/3 | 3/1/3 | 1.00 |
| BMI, kg/m2 | 37.7 ± 2.64 | 35.4 ± 2.54 | .15 |
| Waist to hip ratio | 0.93 ± 0.01 | 0.91 ± 0.02 | .38 |
| Whole body insulin sensitivity index | 1.45 ± 0.36 | 1.27 ± 0.33 | .49 |
| Fasting glucose, mg/dL | 84.7 ± 2.95 | 87.2 ± 1.90 | .51 |
| Fasting insulin, μU/mLa | 30.4 ± 2.93 | 30.4 ± 8.07 | .39 |
| Hepatic fat content, %a | 3.81 ± 1.83 | 4.45 ± 2.92 | .77 |
| Fasting triglycerides, mg/dLa | 69.0 ± 10.1 | 121.5 ± 15.4 | .02 |
Abbreviations: C, Caucasian; AA, African American; H, Hispanic. Data are expressed as mean ± SEM, unless stated otherwise.
a
Data are expressed as median ± SEM.